Aureus Asset Management, LLC Evolus, Inc. Transaction History

Aureus Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$3.03 - $5.48 $31,208 - $56,444	-10,300 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$3.53 - $12.21 $1.36 Million - $4.72 Million	-386,178 Reduced 97.4%	10,300 $43,000
Q4 2019 Feb 12, 2020	SELL	$11.58 - $17.37 $412,965 - $619,448	-35,662 Reduced 8.25%	396,478 $4.83 Million
Q3 2019 Nov 12, 2019	BUY	$13.91 - $19.87 $316,591 - $452,241	22,760 Added 5.56%	432,140 $6.75 Million
Q2 2019 Aug 14, 2019	BUY	$13.19 - $28.36 $4.41 Million - $9.49 Million	334,580 Added 447.3%	409,380 $5.99 Million
Q1 2019 May 13, 2019	BUY	$12.43 - $28.91 $929,764 - $2.16 Million	74,800 New	74,800 $1.69 Million

169

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $707M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aureus Asset Management, LLC with notifications on news.